Haaijer-Ruskamp FM - Search Results

1

Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

Kasje WN, Denig P, de Graeff PA, Haaijer-Ruskamp FM. Kasje WN, et al. BMC Fam Pract. 2005 May 3;6(1):19. doi: 10.1186/1471-2296-6-19. BMC Fam Pract. 2005. PMID: 15869704 Free PMC article.

2

Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.

Pont LG, Sturkenboom MC, van Gilst WH, Denig P, Haaijer-Ruskamp FM. Pont LG, et al. Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):327-34. doi: 10.1002/pds.809. Pharmacoepidemiol Drug Saf. 2003. PMID: 12812013 Free article.

3

Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.

Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BH, Haaijer-Ruskamp FM. Schaars CF, et al. Diabetes Care. 2004 Jan;27(1):123-8. doi: 10.2337/diacare.27.1.123. Diabetes Care. 2004. PMID: 14693977

4

Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.

Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Kasje WN, et al. Eur J Clin Pharmacol. 2005 Apr;61(2):145-51. doi: 10.1007/s00228-005-0897-6. Epub 2005 Mar 11. Eur J Clin Pharmacol. 2005. PMID: 15761751 Free article.

5

An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice.

Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Kasje WN, et al. J Eval Clin Pract. 2006 Dec;12(6):613-21. doi: 10.1111/j.1365-2753.2005.00625.x. J Eval Clin Pract. 2006. PMID: 17100860 Clinical Trial.

6

Improving drug treatment in general practice.

Veninga CC, Denig P, Zwaagstra R, Haaijer-Ruskamp FM. Veninga CC, et al. J Clin Epidemiol. 2000 Jul;53(7):762-72. doi: 10.1016/s0895-4356(00)00194-3. J Clin Epidemiol. 2000. PMID: 10941955 Clinical Trial.

7

Physicians' views on joint treatment guidelines for primary and secondary care.

Kasje WN, Denig P, De Graeff PA, Haaijer-Ruskamp FM. Kasje WN, et al. Int J Qual Health Care. 2004 Jun;16(3):229-36. doi: 10.1093/intqhc/mzh038. Int J Qual Health Care. 2004. PMID: 15150154

8

Perceived medication adverse effects and coping strategies reported by chronic heart failure patients.

De Smedt RH, Denig P, Haaijer-Ruskamp FM, Jaarsma T. De Smedt RH, et al. Int J Clin Pract. 2009 Feb;63(2):233-42. doi: 10.1111/j.1742-1241.2008.01954.x. Int J Clin Pract. 2009. PMID: 19196362 Clinical Trial.

9

Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level.

Martirosyan L, Haaijer-Ruskamp FM, Braspenning J, Denig P. Martirosyan L, et al. Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1053-9. doi: 10.1002/pds.2248. Epub 2011 Oct 14. Pharmacoepidemiol Drug Saf. 2012. PMID: 22002240

10

Impact of safety-related regulatory action on clinical practice: a systematic review.

Piening S, Haaijer-Ruskamp FM, de Vries JT, van der Elst ME, de Graeff PA, Straus SM, Mol PG. Piening S, et al. Drug Saf. 2012 May 1;35(5):373-85. doi: 10.2165/11599100-000000000-00000. Drug Saf. 2012. PMID: 22480319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters